Skip to Main Content

Paper Details

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA.
0
2023
C3 complement protein, SARS, SARS-CoV, SARS-CoV-2, cyclic amines, mRNA, mRNA vaccines, messenger RNA, mice, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Luke H RhymDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Luke H RhymMassachusetts Institute of Technology
Galit AlterRagon Institute of MGH
Robert LangerDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Robert LangerMassachusetts Institute of Technology
Robert LangerInstitute for Medical Engineering and Science, Massachusetts Institute of Technology
Robert LangerMassachusetts Institute of Technology
  • 1 - 7

Datasets

Release 1.2